Stryker (SYK): Exploring Valuation After Trauma Device Platform Expansions and Strong Organic Growth
Stryker (SYK) is in the spotlight after announcing several key expansions for its trauma device platforms at the Orthopaedic Trauma Association's annual meeting. The company's launch highlights ...
Shares of medical technology company Stryker (NYSE:SYK) fell 2.9% in the afternoon session after it reported underwhelming earnings. Stryker's revenue grew 10.2% year on year to $6.06 billion, meeting ...
Stryker's robust business model focuses on orthopedics and MedSurg & neurotechnology, driving consistent revenue growth through innovative products and strategic M&A deals. The company achieved 10.2% ...
I am downgrading Stryker Corporation to a Hold rating with a fair value of $380 per share, despite strong performance and growth prospects. Stryker's Mako spine and shoulder applications are set to ...
KALAMAZOO, MI — The Stryker Johnston Foundation Board of Directors has announced William Buster as the organization’s next executive director. Buster will join the Kalamazoo organization and work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback